Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001968202-23-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-04-05 | 2023-04-03 | REGN | VAGELOS P ROY | Dir | G - Gift | $0.00 | -259 | 125.5K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-03 | G | D | 259 | $0.00 | 125,493 | I by CLAT | — | — |